Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combing over heritable gene silencing

Marc Damelin, Steen K T Ooi, Timothy H Bestor

    Nature Structural & Molecular Biology
    |February 8, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2025
    Same author

    Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses.

    Nature communications·2024
    Same author

    Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates.

    Molecular cancer therapeutics·2024
    Same author

    Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios.

    Molecular cancer therapeutics·2023
    Same author

    Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates.

    Journal of medicinal chemistry·2023
    Same author

    Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer.

    Molecular cancer therapeutics·2023
    Same journal

    Publisher Correction: Interplay between cohesin and RNA polymerase II in regulating chromatin interactions and gene transcription.

    Nature structural & molecular biology·2026
    Same journal

    An asymmetric non-canonical nucleosome shapes the directionality of transcription outcomes.

    Nature structural & molecular biology·2026
    Same journal

    Structural insights into neurokinin 2 receptor selectivity hold implications for obesity therapeutics.

    Nature structural & molecular biology·2026
    Same journal

    Genome-wide absolute quantification of chromatin looping.

    Nature structural & molecular biology·2026
    Same journal

    Putting numbers on chromatin looping.

    Nature structural & molecular biology·2026
    Same journal

    Transcriptional readthrough progresses from incidental byproduct to therapeutic opportunity.

    Nature structural & molecular biology·2026
    See all related articles